Stay updated on ALN-TTRSC SubQ Clinical Trial
Sign up to get notified when there's something new on the ALN-TTRSC SubQ Clinical Trial page.

Latest updates to the ALN-TTRSC SubQ Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing the previous v3.3.3. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check17 days agoNo Change Detected
- Check32 days agoChange DetectedFooter now displays Revision: v3.3.3; HHS Vulnerability Disclosure and Revision: v3.3.2 were removed.SummaryDifference0.1%

- Check60 days agoChange DetectedThe page's revision history updated: added Revision: v3.3.2 and removed Revision: v3.2.0. The underlying study information remains unchanged.SummaryDifference0.1%

- Check67 days agoChange DetectedThe page no longer displays the government funding operating status notice at the top; no study details, eligibility criteria, locations, or results were changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check82 days agoChange DetectedThe new screenshot shows minor visual adjustments in the Study Overview and Eligibility sections (spacing and formatting changes) with no new or removed content, and core trial details such as title, conditions, interventions, and outcomes remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check111 days agoChange DetectedMajor update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.SummaryDifference6%

Stay in the know with updates to ALN-TTRSC SubQ Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALN-TTRSC SubQ Clinical Trial page.